SillaJen researchers work on anti-cancer drugs (Courtesy of SillaJen) Qureator was co-founded by Jeon Noo-li, a mechanical engineering professor at Seoul National University and a leading expert in ...

LEO Pharma A/S, a global leader in medical dermatology, today announced positive topline results of the phase 2b trial with temtokibart, an investigational IL-22RA1 antagonist, for the potential ...

Shenzhen Neptunus Bioengineering Co. Ltd. A 0.86% ¥5.85B GuangYuYuan Chinese Herbal Medicine Co. Ltd. A 0.78% ¥9.4B Zhejiang Int'l Group Co. Ltd. A 1.43% ¥5.46B Jointown Pharmaceutical Group Co ...

THE WOODLANDS, Texas, May 06, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate in a fireside chat at the 3rd Annual H.C.

These hurdles underscore the urgent need for more effective pharmacological approaches. Ousia Pharma's innovative targeting concept is founded on the groundbreaking discovery that NMDA receptor ...

"We are very excited about the patent approval of our topical pain relief technology in Mexico," said Iris Bincovich, Chief Executive Officer of Innocan Pharma. Innocan Pharma intends to continue ...

"We are excited to enter the next phase of Ousia Pharma's journey, advancing our groundbreaking platform towards clinical development," said Anders B. Klein, PhD, CEO of Ousia Pharma. "The strong ...

Innocan's first fully-granted patent in Mexico Covers Innocan's proprietary cannabis-based pain relief topical Indication of Innocan's growing intellectual property portfolio This patent covers a ...

TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment (TME), ...